Document is current

Any future updates will be listed below

Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022

Crossref DOI link: https://doi.org/10.1136/jitc-2024-009258

Published Online: 2024-08-28

Published Print: 2024-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark